FBLN5 and pancreatic neoplasm: In addition, a study by Mary et al. [21] showed that FBLN5 blocked the interaction between fibronectin and integrins, thereby directly limiting the generation of reactive oxygen species driven by the ECM and promoting pancreatic cancer progression.